Table 3.
Comparison of laboratory data between patients with and without bacterial infection among patients who had fever after TACE and/or RFA.
| Laboratory marker | Patients with fever after TACE and/or RFA | ||
|---|---|---|---|
| With bacterial infection (N = 9) | Without bacterial infection (N = 88) | P value | |
| White blood cells (mm3), median (IQR) | 8600 (6750–11,750) | 8550 (6725–11,000) | 0.985 |
| Neutrophil (%) | 78.9 (72.7–86.6) | 73.6 (67.3–79.6) | 0.147 |
| C-reactive protein (mg/dL) | 3.0 (0.5–15.6) | 1.9 (0.5–5.1) | 0.332 |
| Procalcitonin (ng/mL) | 0.2 (0.2–1.4) | 0.1 (0.1–0.3) | 0.035 |
| T-bilirubin (mg/dL) | 1.4 (1.3–2.4) | 1.0 (0.8–1.5) | 0.009 |
| Alkaline phosphatase (U/L) | 132.0 (118.5–178.0) | 102.5 (82.5–135.8) | 0.038 |
| AST (U/L) | 270.0 (148.5–469.0) | 189.5 (97.8–319.3) | 0.198 |
| ALT (U/L) | 183.0 (51.5–335.0) | 156.5 (63.5–247.5) | 0.580 |
| Prothrombin time (INR) | 1.2 (1.1–1.3) | 1.1 (1.1–1.2) | 0.134 |
| Albumin (g/dL) | 2.5 (3.1–4.1) | 3.7 (3.3–4.0) | 0.881 |
TACE: transarterial chemoembolization; RFA: radiofrequency ablation; IQR: interquartile range; INR: international normalized ratio; AST: aspartate transaminase; ALT: alanine transaminase.